We are live on
!
Find out more
Osaic Holdings Portfolio holdings
AUM
$68.3B
1-Year Est. Return
20.5%
This Fund
S&P 500
This Quarter
Est. Return
-3.08%
1 Year Est. Return
+20.5%
3 Year Est. Return
+61.22%
5 Year Est. Return
+69.4%
10 Year Est. Return
–
AUM
$67.7B
AUM Growth
+$12B
(+22%)
Cap. Flow
+$13.8B
Cap. Flow
% of AUM
20.41%
Top 10 Holdings %
Top 10 Hldgs %
15.72%
Holding
7,728
New
275
Increased
4,629
Reduced
1,668
Closed
336
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$457M |
| 2 |
Apple
AAPL
|
+$371M |
| 3 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$281M |
| 4 |
Invesco BuyBack Achievers ETF
PKW
|
+$280M |
| 5 |
Microsoft
MSFT
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$235M |
| 2 |
iShares Russell Top 200 Growth ETF
IWY
|
+$204M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$189M |
| 4 |
iShares US Treasury Bond ETF
GOVT
|
+$94.1M |
| 5 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$88.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.42% |
| 2 | Financials | 4.58% |
| 3 | Healthcare | 4.15% |
| 4 | Consumer Discretionary | 3.77% |
| 5 | Industrials | 3.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5351
Keros Therapeutics
KROS
$221M
| $28.2K | ﹤0.01% |
884
| – | – |
|
5352
Simplify Volatility Premium ETF
SVOL
$528M
| $28.1K | ﹤0.01% |
1,250
-3,725
| -75% | -$85.2K |
|
5353
Phathom Pharmaceuticals
PHAT
$692M
| $28.1K | ﹤0.01% |
2,713
-1,538
| -36% | -$21.1K |
|
5354
Bowman Consulting
BWMN
$477M
| $28K | ﹤0.01% |
1,000
+375
| +60% | +$11.4K |
|
5355
Structure Therapeutics
GPCR
$3.78B
| $28K | ﹤0.01% |
+556
| New | +$17.9K |
|
5356
ZipRecruiter
ZIP
$423M
| $27.8K | ﹤0.01% |
2,323
-5,913
| -72% | -$96.3K |
|
5357
CALL
Icahn Enterprises
IEP
$5.3B
| $27.8K | ﹤0.01% |
100
| – | – |
|
|
CCEC
5358
Capital Clean Energy Carriers
CCEC
$1.35B
| $27.7K | ﹤0.01% |
1,980
-102
| -5% | -$1.49K |
|
5359
Broadwind
BWEN
$109M
| $27.6K | ﹤0.01% |
8,636
+1,500
| +21% | +$5.7K |
|
5360
Syndax Pharmaceuticals
SNDX
$1.82B
| $27.6K | ﹤0.01% |
1,900
+200
| +12% | +$3.78K |
|
|
NETI
5361
DELISTED
Eneti Inc.
NETI
| $27.5K | ﹤0.01% |
2,730
+2,202
| +417% | +$25.3K |
|
5362
Foster
FSTR
$432M
| $27.5K | ﹤0.01% |
1,453
+388
| +36% | +$6.42K |
|
|
GTHX
5363
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $27.5K | ﹤0.01% |
19,082
+10,718
| +128% | +$20.7K |
|
5364
Atea Pharmaceuticals
AVIR
$420M
| $27.5K | ﹤0.01% |
9,151
+1,997
| +28% | +$6.79K |
|
|
PBBK
5365
DELISTED
PB Bankshares
PBBK
| $27.5K | ﹤0.01% |
+2,241
| New | +$29.4K |
|
|
VIA
5366
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $27.3K | ﹤0.01% |
3,718
-954
| -20% | -$7.86K |
|
5367
Enliven Therapeutics
ELVN
$4.43B
| $27.3K | ﹤0.01% |
2,000
+1,000
| +100% | +$16.8K |
|
5368
iRadimed
IRMD
$1.18B
| $27.3K | ﹤0.01% |
614
+10
| +2% | +$465 |
|
|
IQIN
5369
DELISTED
NYLI 500 International ETF
IQIN
| $27.2K | ﹤0.01% |
892
+795
| +820% | +$25K |
|
|
GLV
5370
Clough Global Dividend & Income Fund
GLV
$78.1M
| $27.2K | ﹤0.01% |
5,474
-9,738
| -64% | -$53K |
|
5371
Suzano
SUZ
$10.1B
| $27K | ﹤0.01% |
2,513
-1,553
| -38% | -$15.6K |
|
5372
Citizens Community Bancorp
CZWI
$202M
| $27K | ﹤0.01% |
2,813
+291
| +12% | +$2.9K |
|
5373
Franklin FTSE Mexico ETF
FLMX
$86.7M
| $27K | ﹤0.01% |
936
-1,386
| -60% | -$42.4K |
|
|
LRFC
5374
DELISTED
Logan Ridge Finance Corp
LRFC
| $27K | ﹤0.01% |
1,300
| – | – |
|
5375
Apyx Medical
APYX
$171M
| $26.8K | ﹤0.01% |
8,375
-10,235
| -55% | -$47.7K |
|
Similar funds
Osaic Holdings's Q3 2023 Portfolio in Review
As of Q3 2023, Osaic Holdings held 7,728 positions worth $67.7B, up 22% from $55.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Osaic Holdings deployed $13.8B of net new capital in Q3 2023, opening 275 new positions and adding to 4,629 existing holdings. Its largest new stake was FT Vest US Equity Moderate Buffer ETF July: 1,031,784 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 9.4% of assets, down from 9.6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Vanguard Morningstar Total Stock Market ETF, an estimated $235M trimmed.
- Osaic Holdings's largest Q3 2023 buy was FT Vest US Equity Moderate Buffer ETF July: 1,031,784 shares worth $30.9M.
- Osaic Holdings added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $457M increase.
- Osaic Holdings's biggest Q3 2023 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $235M.
- Osaic Holdings fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $7.11M.
- Osaic Holdings's ten largest holdings make up 16% of its $67.7B portfolio in Q3 2023.
- Osaic Holdings opened 275 new positions and closed 336 in Q3 2023.
- Osaic Holdings's portfolio value rose 22% quarter-over-quarter to $67.7B.
Based on Osaic Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.